Page last updated: 2024-09-05

lapatinib and Experimental Radiation Injuries

lapatinib has been researched along with Experimental Radiation Injuries in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hoving, S; Russell, NS; Seemann, I; Song, JY; Stewart, FA; te Poele, JA	1

Other Studies

1 other study(ies) available for lapatinib and Experimental Radiation Injuries

Article	Year
Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents. Breast cancer research and treatment, 2013, Volume: 141, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Cell Survival; Cells, Cultured; Coronary Vessels; Doxorubicin; Fibrosis; Heart Diseases; Humans; Lapatinib; Male; Mice; Mice, Inbred C57BL; Microvessels; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Pericardium; Quinazolines; Radiation Injuries, Experimental; Receptor, ErbB-2; Trastuzumab; Ventricular Function, Left	2013

Article

Year

Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents.

Breast cancer research and treatment, 2013, Volume: 141, Issue:3

Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Cell Survival; Cells, Cultured; Coronary Vessels; Doxorubicin; Fibrosis; Heart Diseases; Humans; Lapatinib; Male; Mice; Mice, Inbred C57BL; Microvessels; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Pericardium; Quinazolines; Radiation Injuries, Experimental; Receptor, ErbB-2; Trastuzumab; Ventricular Function, Left

2013